Daily Archives: Junho 11, 2021 | LinksMedicus Free Medical News & Perspectives

Alta taxa de vacinação contra COVID pode proteger os não vacinados.

11 Jun, 2021 | 10:45h

High COVID vaccine uptake may protect the unvaccinated – CIDRAP

Estudo original: Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals – Nature Medicine

Comentários no Twitter

Just published @NatureMedicine
Evidence that "vaccination not only protects individuals who have been vaccinated but also provides cross-protection to unvaccinated individuals in the community" as seen in kids benefiting from high % of adults vaxxedhttps://t.co/IPQo6WTFZX pic.twitter.com/jtfD93onnn

— Eric Topol (@EricTopol) June 10, 2021

Nature Medicine: "On average, for each 20% increase in the number of vaccinated people in a given population, the number of positive SARS-CoV-2 tests in the unvaccinated population in the same community decreased approximately two fold." https://t.co/QhMqSbZDtc

— Niklas Fagerström (@niklasf) June 10, 2021

Perspectiva | A vacinação de adultos impede que as crianças também disseminem a COVID?

11 Jun, 2021 | 10:44h

Does vaccinating adults stop kids from spreading COVID too? – Nature

Segundo a OMS, a doação dos EUA de 500 milhões de doses da vacina da Pfizer pode ajudar a “virar o jogo” num momento em que a África enfrenta falta de doses.

11 Jun, 2021 | 10:43h

US Donation of 500 Million Pfizer Vaccines Could Help ‘Turn Tide’ as Africa Runs Out of Doses, Says WHO – Health Policy Watch

CDC afirma que casos de inflamação cardíaca em pessoas de 16 a 24 anos depois da segunda dose da vacina contra Covid foram acima do esperado, mas, ainda assim, raros.

11 Jun, 2021 | 10:42h

CDC says heart inflammation cases were higher than expected in 16- to 24-year-olds after second Covid vaccine shot, but still rare – CNBC

Ver também: CDC plans “emergency meeting” on rare heart inflammation following COVID-19 vaccines – CBC News

Relacionado: Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men.

Opinião | O futuro da preparação para uma pandemia: coordenação ágil em torno de estudos clínicos.

11 Jun, 2021 | 10:40h

The future of pandemic preparedness: agile coordination around clinical trials – STAT

Estratégias de oxigenação não invasiva para insuficiência respiratória devido ao COVID-19: uma concisa revisão da literatura na era pré e peri-COVID.

11 Jun, 2021 | 10:37h

Non-invasive Oxygenation Strategies for Respiratory Failure with COVID-19: A concise narrative review of literature in pre and mid-COVID-19 era – Anaesthesia Critical Care & Pain Medicine

Imunidade contra SARS-CoV-2 adquirida naturalmente perdura por até 11 meses após a infecção.

11 Jun, 2021 | 10:36h

Naturally acquired SARS-CoV-2 immunity persists for up to 11 months following infection – The Journal of Infectious Diseases

Opinião | A variante Delta da Covid-19 representa uma ameaça à nossa volta ao “normal”.

11 Jun, 2021 | 10:36h

The Covid-19 Delta variant poses a threat to our return to ‘normal’ – CNN

Comentário no Twitter

In @CNNOpinion I offer thoughts on how the COVID Delta variant should cause the US to rethink national SARS-CoV-2 goal setting…as well as adjust other policy and communications strategies in response to the unique challenges posed by Delta. https://t.co/N4j5HdREnY @ASPPHtweets

— David R Holtgrave (@HoltgraveHealth) June 10, 2021

Relatório OMS | Resistência antimicrobiana global e uso do sistema de vigilância.

11 Jun, 2021 | 10:35h

Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: 2021 – World Health Organization

Comunicado de imprensa: Record response to WHO’s call for antimicrobial resistance surveillance reports in 2020 – World Health Organization

Comentário: WHO reveals new global antibiotic resistance data, more concerns – CIDRAP

Comentário no Twitter (fio – clique para saber mais)

WHO received over 3⃣ million reports for the Global #AntimicrobialResistance and Use Surveillance System (GLASS)

The more information we have the better placed the 🌏
is to tackle this increasingly serious health threat.

👉 https://t.co/ccZCzdyZUc
pic.twitter.com/DMuLwVu4rC

— World Health Organization (WHO) (@WHO) June 9, 2021

Estudo randomizado | Em pacientes com fibrilação atrial ou valvas cardíacas mecânicas, tratados com warfarina e submetidos à cirurgia, o tratamento pós-operatório com “ponte” (bridging treatment) de heparina de baixo peso molecular não evitou tromboembolismo maior.

11 Jun, 2021 | 10:33h

Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial – The BMJ